The Dow Chemical Firm (NYSE:DOW) [Trend Analysis] knocking active thrust in leading trading session, shares a loss of -0.17% to 51.51 with about 5.41 Million shares have changed hands in this session. Dow Chemical Co. (DOW) and Dow Corning Corp. reported the retirement plan of Robert Hansen as chairman, chief executive officer and president upon the completion of Dow’s ownership restructure transaction with Corning, Inc. Hansen will ensure a smooth ownership transition for the Dow Corning Silicones business.
The accord is predictable to close in the q2 of 2016. Hansen has been with the firm since 1982 and was appointedpresident in 2010, chief executive officer in 2011 and was elected chairman in 2013. The stock is going forward its fifty-two week low with 50.84% and lagging behind from its 52-week high price with -8.17%.
Likewise the positive performance for the quarter recorded as 8.30% and for the year was 4.67%, while the YTD performance remained at 0.96%. DOW has Average True Range for 14 days of 0.90.
Shares of Bank of America Corporation (NYSE:BAC) [Trend Analysis] swings enthusiastically in regular trading session, it raise of 0.57% to close at $14.01. CSX EVP and CFO Frank Lonegro spoke with investors and analysts at the Bank of America Merrill Lynch Transportation Conference in Boston, updating them on second-quarter volume trends and the firm’s plans to continue managing through the transition in its business mix. “We are seeing year-to-date volume declines across most of our markets, reflecting continued low global commodity prices, the strong U.S. dollar, and the transition in the energy markets,” Lonegro stated.
“For the q2, we now expect high-single digit volume declines, which will negatively impact q2 earnings.” At the same time, continued service improvements are supporting strong pricing through this business cycle. With the impact of improving service and ongoing initiatives to drive additional network efficiency, CSX now expects efficiency savings for the full year to exceed $250 million, approaching a firm record. Moving forward to saw long-term intention, BAC experts calculate Return on Investment of 4.40%. The stock is going forward its fifty-two week low with 27.96% and lagging behind from its 52-week high price with -23.44%. BAC last month stock price volatility remained 2.36%.
Great Basin Scientific, Inc. (NASDAQ:GBSN) [Trend Analysis] retains strong position in active trade, as shares scoring -3.89% to $1.73 in a active trade session, while looking at the shares volume, about 256289 shares have changed hands in this session. Great Basin Scientific initiates a clinical trial for its sample-to-result Bordatella Direct Test; intends to submit its 510K Clearance application for the Bordatella Direct Test to the FDA in fourth quarter of this year (GBSN).
The firm reported it has initiated a clinical trial for its sample-to-result Bordatella Direct Test, which will detect, directly from patient specimen, Bordatella pertussis, a bacterium causing a highly contagious respiratory disease ordinarily known as whooping cough.
This is the first of five clinical trials the Firm plans to initiate in 2016. Great Basin intends to submit its 510k Clearance application for the Bordatella Direct Test to the FDA in the fourth quarter of this year, on-track with guidance before issued by the Firm. The firm has institutional ownership of 9.60%, while insider ownership included 4.12%. GBSN attains analyst recommendation of 3.00 with week’s performance of -25.93%.